Popit
Providing smart consumer devices that improve treatment by increasing patients' medical adherence.
- Healthtech
- Series A
Location
Espoo, Finland
Revenue size
EUR 100,000 - 499,999
Year founded
2015
Funding raised
EUR 1.1 million
Founders
Timo Heikkilä, Teemu Piirainen, Marko Nirhola, Janne Sahlman
Most relevant investors
Butterfly Ventures, Amor & Labor Oy, Business Finland
Team size
1-9
Problem
According to the World Health Organization (WHO), 50% of patients miss medications, most often because they simply forget. Non-adherent patients have twice the mortality and suffer a lower quality of life. In addition, pharmaceuticals and healthcare professionals have little or no data on when and how prescribed medication is taken by patients.
SOLUTION
Popit has developed a device that can be attached to patients’ pill sheets where it monitors how medications are taken. This data is sent to a medically certified app that reminds the patient of missed medication when necessary. The technology is patented and improves patient adherence and treatment outcomes, and provides medication-intake data to telehealth platforms. The solution is clinically validated to reduce missed pills by 80%, thus enhancing the treatment of users.
KEY CUSTOMERS & INTERNATIONAL PRESENCE
Popit provides solutions for both individual customers as well as healthcare systems and pharmaceutical companies and femtech companies, including Pfizer, Novartis, Almirall and Fermata.
Unique selling point
For patients:
- Automatic and passive tracking.
- No need for manual input. Only relevant reminders.
For pharma and medical institutions:
- Improve medication adherence
- No changes to blister packaging required.
- Differentiation from competition
- Access to medication intake data at a large scale
Asia Connection
Popit has already shipped its first batch of products to Japan, where the reviews have been overwhelmingly positive. Popit is now looking for clients throughout Asia and possibly also funding.